BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 11448933)

  • 1. Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors.
    Reiss K; Tu X; Romano G; Peruzzi F; Wang JY; Baserga R
    Clin Cancer Res; 2001 Jul; 7(7):2134-44. PubMed ID: 11448933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.
    Reiss K; D'Ambrosio C; Tu X; Tu C; Baserga R
    Clin Cancer Res; 1998 Nov; 4(11):2647-55. PubMed ID: 9829727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of pro-apoptotic p38-MAPK pathway in the prostate cancer cell line M12 expressing a truncated IGF-IR.
    Wu J; Haugk K; Plymate SR
    Horm Metab Res; 2003; 35(11-12):751-7. PubMed ID: 14710354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
    D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
    Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.
    Hongo A; Kuramoto H; Nakamura Y; Hasegawa K; Nakamura K; Kodama J; Hiramatsu Y
    Cancer Res; 2003 Nov; 63(22):7834-9. PubMed ID: 14633710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone.
    Weigent DA; Arnold RE
    Cell Immunol; 2005 Mar; 234(1):54-66. PubMed ID: 15964559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
    Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF
    Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
    Blanquart C; Boute N; Lacasa D; Issad T
    Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
    Werner H; Maor S
    Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
    Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
    Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H; Tu X; Liu M; Baserga R
    J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
    Sun H; Tu X; Baserga R
    Cancer Res; 2006 Dec; 66(23):11106-9. PubMed ID: 17145851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.
    Maor S; Yosepovich A; Papa MZ; Yarden RI; Mayer D; Friedman E; Werner H
    Cancer Lett; 2007 Nov; 257(2):236-43. PubMed ID: 17766039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.